The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Result of AGM

30 Jul 2018 12:25

RNS Number : 1729W
G3 Exploration Limited
30 July 2018
 

 30 July 2018

 

 

 

G3 Exploration Limited

 

("G3E" or "the Company")

 

Result of AGM

 

G3 Exploration Ltd. (LSE: G3E), an independent specialist in the exploration and development of coal bed methane gas (CBM) with roots in China and a focus on international expansion, is pleased to announce that all the resolutions were duly passed at its Annual General Meeting ("AGM") held on Monday, 30 July 2018.

 

A copy of the presentation delivered at the Annual General Meeting will be available on the Company's website later today at www.g3-ex.com.

 

For further information on the Company and its activities, please refer to the website at www.g3-ex.com or contact:

 

FTI Consulting:

Kim Camilleri Tel: +44 20 3727 1000

About G3 Exploration Ltd.

 

An independent specialist in the exploration and development of coal bed methane gas (CBM); G3 Exploration has accumulated a unique wealth of experience through its significant 25 year track record of technology-led exploration and drilling success in CBM, across different geographies.

 

G3 Exploration's intention is to leverage its expertise, monetise its current 7112km² acreage position in mainland China and widen its asset portfolio into other prospective geographies across Africa, Europe and Asia, utilising its proprietary knowledge and experience in exploiting CBM resources. Furthermore, G3 Exploration has interests in Green Dragon Gas, which comprises of two producing assets with an acreage of 455km2 in Shanxi province, China.

 

G3 Exploration is listed on the main market of the London Stock Exchange (LSE: G3E).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGURORRWKABOAR

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.